MétaCan
Menu
Back to cohort
Record W4410517499 · doi:10.1016/j.eclinm.2025.103246

Sex differences in discontinuations due to side effects of second-generation integrase strand transfer inhibitors: a systematic review and meta-analysis

2025· review· en· W4410517499 on OpenAlexaffabout
Tetiana Povshedna, Erin Ready, Hélène C. F. Côté, Melanie C. M. Murray, Elizabeth M. King

Bibliographic record

VenueEClinicalMedicine · 2025
Typereview
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsB.C. Women's Hospital & Health CentreSt. Paul's HospitalSimon Fraser UniversityWomen's Health Research InstituteUniversity of British Columbia
Fundersnot available
KeywordsMedicineMeta-analysisIntegrasePharmacologyTraditional medicineVirologyHuman immunodeficiency virus (HIV)Internal medicine

Abstract

fetched live from OpenAlex

Background: Dolutegravir and bictegravir are frequently prescribed second-generation integrase strand transfer inhibitors. Although sex and gender influence drug pharmacokinetics, little is known about the differences in side effects experienced by cisgender men and women on these agents. Therefore, we synthesize data on sex-disaggregated side effects leading to discontinuation in dolutegravir/bictegravir-based regimens. Methods: We conducted a systematic review and meta-analysis (PROSPERO: CRD42023427891) by searching Medline, Embase, Web of Science, and Scopus for studies published from January 2010 to August 2024. We included randomized controlled trials and observational studies reporting sex-disaggregated discontinuations of dolutegravir/bictegravir-based regimens due to general or neuropsychiatric side effects. Studies in pregnancy, post-partum, pediatrics, co-infections (e.g., TB), and monotherapy were excluded. Two reviewers screened and extracted data. Risk of bias was assessed using an adapted version of the Newcastle-Ottawa scale for cohort studies. Meta-analysis was conducted using random effects models on studies reporting raw dolutegravir discontinuations by sex. Findings: We screened 4179 abstracts, conducted 505 full-text reviews, and included 17 observational studies in the review (15 on dolutegravir, two on bictegravir). Notably, 287/505 articles were excluded for lack of sex-disaggregated data. Fifteen dolutegravir studies reported outcomes for 32,352 people with HIV (7506 women, 24,846 men). Meta-analysis showed higher odds of dolutegravir discontinuation due to side effects in women vs men (9.3% vs 7.5%; OR: 1.40 [1.23-1.60], p < 0.001). A second meta-analysis on neuropsychiatric-related discontinuations found no sex differences (3.5% in women vs 3.3% in men; OR: 1.14 [0.84-1.56], p = 0.40). Only two bictegravir studies met inclusion criteria and showed conflicting results. Interpretation: This review reports signals of higher discontinuation rates of dolutegravir due to general side effects in women compared to men which may not be accounted for by neuropsychiatric effects. Further research is needed to determine whether these trends extend to other second-generation integrase strand transfer inhibitors, such as bictegravir and cabotegravir, and to better understand the specific side effects contributing to dolutegravir discontinuation in women. Additionally, the lack of sex-disaggregated reporting during our literature search identifies a need to prioritize sex/gender-based analyses in future research on antiretrovirals. Funding: None.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.023
metaresearch head score (Gemma)0.051
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.023
Threshold uncertainty score0.120

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0230.051
Meta-epidemiology (narrow)0.0030.002
Meta-epidemiology (broad)0.0190.047
Bibliometrics0.0090.009
Science and technology studies0.0010.001
Scholarly communication0.0040.002
Open science0.0020.002
Research integrity0.0020.002
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.079
GPT teacher head0.378
Teacher spread0.299 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueEClinicalMedicineSame topicHIV/AIDS drug development and treatmentFrench-language works237,207